Article info
PDFHarm
Cohort study
Use of psychotropic medication in Alzheimer's disease is associated with more rapid cognitive and functional decline
- Correspondence to
: Dr Edward C Lauterbach
Departments of Psychiatry and Internal Medicine (Neurology Section), Mercer University School of Medicine, 655 First Street, Macon, GA 31201, USA; eclbgnp{at}earthlink.net
Citation
Use of psychotropic medication in Alzheimer's disease is associated with more rapid cognitive and functional decline
Publication history
- First published March 7, 2013.
Online issue publication
December 09, 2022
Article Versions
- Previous version (9 December 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions